Contract Development Manufacturing Organizations based outside China are likely to contribute in order to maintain a steady supply of APIs globally
Non-Chinese CDMOs To Gain API Manufacturing Market Share
The growth of Contract Development Manufacturing Organizations and the manufacturing of APIs has been credited to a rise in the demand for generic drugs, patent expirations, and biological innovations. However, the COVID-19 pandemic has drastically increased the demand for innovations and generic drugs, recently. Although there has been an increased demand for APIs catering to these fields, the supply of API has proved challenging.
